查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1259875

糖尿病治疗药市场占有率·规模·趋势·产业分析·预测 (2023年～2032年): 药物类别·给药途径·糖尿病类型·终端用户·各地区

Diabetes Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class, By Route of Administration; By Diabetes Type: By End Use: By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球糖尿病治疗药的市场规模到2032年前将成长到1,035亿2,000万美元的规模。

本报告提供全球糖尿病治疗药的市场调查，彙整市场概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·地区/各主要国家的明细，竞争环境，主要企业简介等资讯。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球糖尿病治疗药市场洞察

  • 产业概要
  • 市场动态
    • 推动要素和机会
    • 阻碍因素与课题
  • 波特的五力分析
  • PESTEL分析
  • 产业趋势
  • 价值链分析
  • COVID-19:影响分析

第5章 全球糖尿病治疗药市场:各类药物

  • 主要调查结果
  • 糖原样[月太]-1(GLP-1)
  • 二?基??-4(DPP-4)
  • 钠葡萄糖共同输送体2抑制剂(SGCL2)
  • 胰岛素
  • 磺酰尿素类
  • Glitazone
  • 其他

第6章 全球糖尿病治疗药市场:各给药途径

  • 主要调查结果
  • 口服
  • 静脉内注射
  • 皮下注射

第7章 全球糖尿病治疗药市场:糖尿病各类型

  • 主要调查结果
  • 第一型
  • 2型

第8章 全球糖尿病治疗药市场:各流通管道

  • 主要调查结果
  • 零售药局
  • 线上药局
  • 医院药局

第9章 全球糖尿病治疗药市场:各地区

  • 主要调查结果
  • 北美
  • 欧洲
  • 亚太地区
  • 中东及非洲
  • 南美

第10章 竞争情形

  • 扩张·收购的分析
  • 联盟/合作/协定/展示会

第11章 企业简介

  • Novo Nordisk A/S
  • Merck &Co
  • Novartis AG
  • Eli Lily and Company
  • Johnson & Johnson
  • Boehringer Ingelheim GmbH
  • Sanofi
  • AstraZeneca
  • Pfizer
  • Roche Holding AG
Product Code: PM1327

The global diabetes drugs market size is expected to reach USD 103.52 billion by 2032, according to a new study by Polaris Market Research. The report "Diabetes Drugs Market By Drug Class (Glycogen-like peptide-1 (GLP-1), Dipeptidyl-peptidase-4 (DPP-4), Sodium-glucose co-transporter 2 inhibitor (SGCL2), Insulin, Others), By Route of Administration; By Diabetes Type: By End Users: By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The diabetes drug industry is expected to grow at the quickest rate over the forecast period owing to the fastest growth of the diabetic population globally and the availability of affordable and effective diabetic drugs by market players in the last few years.

Diabetes drugs are primarily used to control the blood sugar level among patients. Type 1 diabetic patients are mostly recommended to take insulin to maintain their blood sugar levels. Other different classes of drugs are also being researched and produced for type 2 diabetic patients by various market players.

The growing investments in R&D have available a wide price range of drugs in the market. For instance, Glenmark, an Indian pharmaceutical company, is the first to launch a fixed-dose combination for type 2 diabetic patients at a very affordable rate.

Further, the launch of generic insulin in the market supplements the body's natural insulin intending to achieve normal blood sugar levels in mostly type 1 diabetic patients. For instance, Novo Nordisk, a Denmark-based pharmaceutical company, introduced various innovative insulin injection pens, such as disposable pre-filled pens, smart connected pens, and durable pens with replaceable insulin cartridges, which can easily be used.

North America is anticipated to dominate the diabetes drugs market in the forecast period due to the higher prevalence of diabetes owing to an increasingly sedentary lifestyle, higher consumer awareness, and increased FDA approvals of diabetic drugs. The inactive and unhealthy eating habits among millennials and adults have upsurged the obese and overweight population in countries such as the U.S. and Canada, dramatically increasing the risk of type 2 diabetes disorder.

Diabetes Drugs Market Report Highlights:

The COVID-19 pandemic had an overall positive impact on the diabetes drugs market in the long run. Lockdown and social distancing have negatively impacted diabetic patients as patients didn't check up and test their blood sugar by physically visiting the labs. Post covid has increased consumer awareness towards proper diabetic management through regular checkups and physical exercise.

The online pharmacy is anticipated to witness the highest growth due to faster technological adoption by patients in the post-pandemic period. Developing economies such as India have registered significant growth in ordering various drugs through online channels due to multiple benefits such as discounts and easy refunds.

Asia pacific diabetes drugs market is projected to grow at the fastest CAGR in the forecast period. The major driving factor for the growth is the large diabetic population in countries such as China, India, and Japan.

Increasing disposable income and rise in rapid urbanization the sugar diets and junk foods among inhabitants which causes more risk towards lifestyle disorders and diseases such as diabetes.

Polaris Market Research has segmented the Diabetes Drugs Market report based on Drug class, route of administration, diabetes type, distribution channel, and region:

Diabetes Drugs Market, Drug class Outlook (Revenue - USD Billion, 2019 - 2032)

Glycogen-like peptide-1 (GLP-1)

Dipeptidyl-peptidase-4 (DPP-4)

Sodium glucose co-transporter 2 inhibitor (SGCL2)

Insulin

Sulfonylureas

Glitazones

Others

Diabetes Drugs Market, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Oral

Intravenous

Subcutaneous

Diabetes Drugs Market, Diabetes Type Outlook (Revenue - USD Billion, 2019- 2032)

Type 1

Type 2

Diabetes Drugs Market, Distribution Channel Outlook (Revenue - USD Billion, 2019- 2032)

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Diabetes Drugs Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Diabetes Drug Market Insights

  • 4.1. Diabetes Drug - Industry Snapshot
  • 4.2. Diabetes Drug Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased the diabetic population
      • 4.2.1.2. Rising investments in R&D for new drug
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Diabetes Drug Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Diabetes Drug Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • 5.3. Glycogen-like peptide-1 (GLP-1)
    • 5.3.1. Global Diabetes Drug Market, by Glycogen-like peptide-1 (GLP-1), by Region, 2019-2032 (USD Billion)
  • 5.4. Dipeptidyl-peptidase-4 (DPP-4)
    • 5.4.1. Global Diabetes Drug Market, by Dipeptidyl-peptidase-4 (DPP-4), by Region, 2019-2032 (USD Billion)
  • 5.5. Sodium glucose co-transporter 2 inhibitor (SGCL2)
    • 5.5.1. Global Diabetes Drug Market, by Sodium glucose co-transporter 2 inhibitor (SGCL2), by Region, 2019-2032 (USD Billion)
  • 5.6. Insulin
    • 5.6.1. Global Diabetes Drug Market, by Insulin, by Region, 2019-2032 (USD Billion)
  • 5.7. Sulfonylureas
    • 5.7.1. Global Diabetes Drug Market, by Sulfonylureas, by Region, 2019-2032 (USD Billion)
  • 5.8. Glitazones
    • 5.8.1. Global Diabetes Drug Market, by Glitazones, by Region, 2019-2032 (USD Billion)
  • 5.9. Others
    • 5.9.1. Global Diabetes Drug Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Diabetes Drug Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Diabetes Drug Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Intravenous
    • 6.4.1. Global Diabetes Drug Market, by Intravenous, by Region, 2019-2032 (USD Billion)
  • 6.5. Subcutaneous
    • 6.5.1. Global Diabetes Drug Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)

7. Global Diabetes Drug Market, by Diabetes Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • 7.3. Type 1
    • 7.3.1. Global Diabetes Drug Market, by Type 1, by Region, 2019-2032 (USD Billion)
  • 7.4. Type 2
    • 7.4.1. Global Diabetes Drug Market, by Type 2, by Region, 2019-2032 (USD Billion)

8. Global Diabetes Drug Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Retail Pharmacies
    • 8.3.1. Global Diabetes Drug Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.4. Online Pharmacies
    • 8.4.1. Global Diabetes Drug Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.5. Hospital Pharmacies
    • 8.5.1. Global Diabetes Drug Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)

9. Global Diabetes Drug Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Diabetes Drug Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Diabetes Drug Market - North America
    • 9.3.1. North America: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.3.2. North America: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.3. North America: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.4. North America: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.3.5. Diabetes Drug Market - U.S.
      • 9.3.5.1. U.S.: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.3.6. Diabetes Drug Market - Canada
      • 9.3.6.1. Canada: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • 9.4. Diabetes Drug Market - Europe
    • 9.4.1. Europe: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.4.5. Diabetes Drug Market - UK
      • 9.4.5.1. UK: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.4.6. Diabetes Drug Market - France
      • 9.4.6.1. France: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.4.7. Diabetes Drug Market - Germany
      • 9.4.7.1. Germany: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.4.8. Diabetes Drug Market - Italy
      • 9.4.8.1. Italy: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.4.9. Diabetes Drug Market - Spain
      • 9.4.9.1. Spain: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.4.10. Diabetes Drug Market - Netherlands
      • 9.4.10.1. Netherlands: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.4.11. Diabetes Drug Market - Russia
      • 9.4.11.1. Russia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • 9.5. Diabetes Drug Market - Asia Pacific
    • 9.5.1. Asia Pacific: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.5.5. Diabetes Drug Market - China
      • 9.5.5.1. China: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.5.6. Diabetes Drug Market - India
      • 9.5.6.1. India: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.5.7. Diabetes Drug Market - Japan
      • 9.5.7.1. Japan: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.5.8. Diabetes Drug Market - Malaysia
      • 9.5.8.1. Malaysia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.5.9. Diabetes Drug Market - Indonesia
      • 9.5.9.1. Indonesia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.5.10. Diabetes Drug Market - South Korea
      • 9.5.10.1. South Korea: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • 9.6. Diabetes Drug Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.6.5. Diabetes Drug Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.6.6. Diabetes Drug Market - South Africa
      • 9.6.6.1. South Africa: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.6.7. Diabetes Drug Market - Israel
      • 9.6.7.1. Israel: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.6.8. Diabetes Drug Market - UAE
      • 9.6.8.1. UAE: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • 9.7. Diabetes Drug Market - Latin America
    • 9.7.1. Latin America: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.7.5. Diabetes Drug Market - Mexico
      • 9.7.5.1. Mexico: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.7.6. Diabetes Drug Market - Brazil
      • 9.7.6.1. Brazil: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
    • 9.7.7. Diabetes Drug Market - Argentina
      • 9.7.7.1. Argentina: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Novo Nordisk A/S
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Merck &Co
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Novartis AG
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eli Lily and Company
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Johnson & Johnson
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Boehringer Ingelheim GmbH
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Sanofi
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. AstraZeneca
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Pfizer
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Roche Holding AG
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables

  • Table 1 Global Diabetes Drug Market, by Drug Class, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Diabetes Drug Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Diabetes Drug Market, by Diabetes Type, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Diabetes Drug Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Diabetes Drug Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 7 North America: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 9 North America: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 11 U.S.: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 12 U.S.: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 13 U.S.: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Canada: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 15 Canada: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Canada: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 18 Europe: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 19 Europe: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 20 Europe: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 21 Europe: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 23 Germany: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Germany: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 France: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 27 France: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 France: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 29 France: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 30 UK: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 31 UK: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 32 UK: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 33 UK: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Italy: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 35 Italy: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 36 Italy: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 37 Italy: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 42 Spain: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 43 Spain: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 44 Spain: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 45 Spain: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Russia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 47 Russia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Russia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 49 Russia: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 54 China: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 55 China: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 56 China: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 57 China: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 Japan: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 59 Japan: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 60 Japan: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 61 Japan: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 India: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 63 India: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 India: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 65 India: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 South Korea: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 75 South Korea: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 South Korea: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 77 South Korea: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 78 Latin America: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 79 Latin America: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 80 Latin America: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 81 Latin America: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 83 Brazil: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Brazil: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 85 Brazil: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Mexico: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 87 Mexico: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Mexico: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 89 Mexico: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 90 Argentina: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 91 Argentina: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 92 Argentina: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 93 Argentina: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 98 UAE: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 99 UAE: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 100 UAE: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 101 UAE: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 South Africa: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 107 South Africa: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 South Africa: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 109 South Africa: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 110 Israel: Diabetes Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 111 Israel: Diabetes Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 112 Israel: Diabetes Drug Market, by Diabetes Type, 2019-2032 (USD Billion)
  • Table 113 Israel: Diabetes Drug Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Diabetes Drug Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Class
  • Figure 7. Global Diabetes Drug Market, by Drug Class, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Diabetes Drug Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Diabetes Drug Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Diabetes Type
  • Figure 13. Global Diabetes Drug Market, by Diabetes Type, 2021 & 2030 (USD Billion)